↓ Skip to main content

Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

Overview of attention for article published in Frontiers in Pharmacology, March 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
2 X users
video
1 YouTube creator

Citations

dimensions_citation
659 Dimensions

Readers on

mendeley
1225 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Published in
Frontiers in Pharmacology, March 2018
DOI 10.3389/fphar.2018.00245
Pubmed ID
Authors

Kulmira Nurgali, R. Thomas Jagoe, Raquel Abalo

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,225 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1225 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 188 15%
Student > Master 156 13%
Student > Ph. D. Student 116 9%
Researcher 80 7%
Student > Doctoral Student 40 3%
Other 156 13%
Unknown 489 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 182 15%
Pharmacology, Toxicology and Pharmaceutical Science 104 8%
Medicine and Dentistry 103 8%
Chemistry 72 6%
Nursing and Health Professions 49 4%
Other 184 15%
Unknown 531 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2020.
All research outputs
#14,379,536
of 23,028,364 outputs
Outputs from Frontiers in Pharmacology
#4,766
of 16,343 outputs
Outputs of similar age
#188,852
of 332,503 outputs
Outputs of similar age from Frontiers in Pharmacology
#119
of 373 outputs
Altmetric has tracked 23,028,364 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,343 research outputs from this source. They receive a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,503 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 373 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.